A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review (Wong, et al, 2024)

Escrito por Michael DeMarco
Michael DeMarco

Psychedelic therapist, clinical sexologist, and Founding Fellow of Psychedelic Institute of Mental Health and Family Therapy / Consultor en Medicina Psicodélica, sexólogo clínico y miembro fundador del Instituto Psicodélico SAS

https://psychedelicmentalhealth.net/michael-demarco-therapist
Anterior

Cognitive behavioral therapy in psychedelic-assisted psychotherapy (an ongoing review, part 1)
Siguiente

Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis (Kwan, et al, 2024)